FDA Says Hospira Plant Continues To Have Quality Issues
FDA inspectors reported 20 observations to Hospira upon completion of a three-week inspection of its Rocky Mount, N.C., plant on Friday, according to a securities filing by the company. Three of the items were repeat observations, Hospira said.
The agency conducted at least two investigations of the facility in...
To view the full article, register now.